Pharma & Biotech

Friday proved to be a turbulent day for pharmaceutical giant Eli Lilly, with three significant developments creating a complex picture...

Medical device specialist Utah Medical Products is confronting significant headwinds, with its latest quarterly results revealing a pronounced contraction in...

Danish pharmaceutical giant Novo Nordisk is implementing a sweeping cost-cutting initiative that carries substantial near-term pain. The company's ambitious plan...

Telehealth provider Hims & Hers Health is making a bold strategic move to capture a significant share of the lucrative...

Shares of Merit Medical Systems are trading quietly around $93.24 as investors monitor two significant near-term developments. Market attention remains...

The biopharmaceutical company Larimar Therapeutics enters a decisive period with two significant clinical milestones scheduled for September 2025. These events...

Moderna's stock remains under significant pressure despite achieving a critical regulatory milestone. The U.S. Food and Drug Administration recently granted...

The investment thesis for Summit Therapeutics hinges entirely on a single developmental asset: ivonescimab. The biotechnology firm finds itself at...

Shares of Cardiff Oncology advanced 1.96% in the latest session, moving from $2.04 to $2.08. However, this modest upward move...

A strategic legal agreement has positioned pharmaceutical giant AbbVie for exceptional financial performance through the next decade. In a development...